Journal of Neurochemistry, 1471-4159

Journal

More filtering options
More filtering options

All authors

Reset
to
101 - 113 out of 113Page size: 25
  1. 2016

  2. Adenosine A₁ receptors control the metabolic recovery after hypoxia in rat hippocampal slices

    João M N Duarte, Rodrigo A Cunha & Rui A. Carvalho, 2016 Mar, In: Journal of Neurochemistry. 136, 5, p. 947-57 11 p.

    Research output: Contribution to journal › Article

  3. Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease: increased NPY levels and differential degradation of the NPY1-30 fragment

    Leona Wagner, Maria Björkqvist, Sofia Hult Lundh, Raik Wolf, Arne Börgel, Dagmar Schlenzig, Hans-Henning Ludwig, Jens-Ulrich Rahfeld, Blair Leavitt, Hans-Ulrich Demuth, Åsa Petersén & Stephan von Hörsten, 2016 Mar 26, In: Journal of Neurochemistry. 137, 5, p. 820-837

    Research output: Contribution to journal › Article

  4. Immunomodulation - a disease-modifying avenue for treatment of Huntington's disease?

    Maria Björkqvist, 2016 Apr 5, In: Journal of Neurochemistry. 137, 5, p. 670-672

    Research output: Contribution to journal › Debate/Note/Editorial

  5. Multisite tyrosine phosphorylation of the N-terminus of Mint1/X11α by Src kinase regulates the trafficking of amyloid precursor protein

    Christopher J R Dunning, Hannah L. Black, Katie L. Andrews, Elizabeth C. Davenport, Michael Conboy, Sangeeta Chawla, Adam A. Dowle, David Ashford, Jerry R. Thomas & Gareth J O Evans, 2016 May 1, In: Journal of Neurochemistry. 137, 4, p. 518-527 10 p.

    Research output: Contribution to journal › Article

  6. How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease?

    Laura A Volpicelli-Daley, Deniz Kirik, Lindsay E Stoyka, David G Standaert & Ashley S Harms, 2016 Oct 1, In: Journal of Neurochemistry. 139, S1, p. 131-155 25 p.

    Research output: Contribution to journal › Review article

  7. Reference measurement procedure for CSF amyloid beta (Aβ)1–42 and the CSF Aβ1–42/Aβ1–40 ratio – a cross-validation study against amyloid PET

    Josef Pannee, Erik Portelius, Lennart Minthon, Johan Gobom, Ulf Andreasson, Henrik Zetterberg, Oskar Hansson & Kaj Blennow, 2016 Nov 1, In: Journal of Neurochemistry. 139, 4, p. 651-658 8 p.

    Research output: Contribution to journal › Article

  8. 2017

  9. Structural and functional brain alterations in a murine model of Angiotensin II-induced hypertension

    Anja Meissner, Jens Minnerup, Guadalupe Soria & Anna M. Planas, 2017, In: Journal of Neurochemistry. 140, 3, p. 509-521

    Research output: Contribution to journal › Article

  11. 2019

  12. How is alpha-synuclein cleared from the cell?

    Leonidas Stefanis, Evangelia Emmanouilidou, Marina Pantazopoulou, Deniz Kirik, Kostas Vekrellis & George K. Tofaris, 2019, In: Journal of Neurochemistry. 150, 5, p. 577-590

    Research output: Contribution to journal › Review article

  14. Targeting sphingosine-1-phosphate signaling to treat heart failure-induced memory deficits

    Anja Meissner, Franziska Uhl, Darcy Lidington, Frank Matthes, Lotte Vanherle & Steffen Sebastian Bolz, 2019 Jul 1, In: Journal of Neurochemistry. 150, S1, p. 185-186 WTH04‐26.

    Research output: Contribution to journal › Published meeting abstract

  15. Sphingosine-1-phosphate signaling in stroke-a potential role for astrocytes

    Hana Matuskova, Frank Matthes, Gabor Petzold & Anja Meissner, 2019 Aug 3, In: Journal of Neurochemistry. 150, Suppl 1, p. 99-99

    Research output: Contribution to journal › Published meeting abstract

  16. 2020
Previous 1 2 3 4 5 Next